D Pharm (Israel) Financial Diagnostics

DPRM -- Israel Stock  

ILS 430.00  0.60  0.14%

The current investor indifference towards the small price fluctuations of D Pharm LTD could raise concerns from investors as the entity closed today at a share price of 429.4 on 1.000 in volume. The company executives did not add any value to D Pharm investors in February. However, most investors can still diversify their portfolios with D Pharm LTD to hedge your portfolio against high-volatility market scenarios. The stock standard deviation of daily returns for 30 days (very short) investing horizon is currently 0.0. The very small Stock volatility is a good signal to investors with longer term investment horizons. This diagnostics interface makes it easy to digest most current publicly released information about D Pharm as well as get updates on important government artifacts including earning estimates, SEC corporate filings and announcements. This module also helps to analysis D Pharm price relationship with some important fundamental indicators such as market cap and management efficiency. Additionally see Investing Opportunities.

D Pharm Note

The company recorded loss per share of 0.14. D Pharm LTD had not issued any dividends in recent years. The entity had 1:50 split on 2016-02-21. D-Pharm LTD., a drug-development company, focuses on the development of drugs for the treatment of central nervous system conditions. D-Pharm LTD. was founded in 1993 and is based in Rehovot, Israel. D Pharm operates under Biotechnology classification in Israel and is traded on Tel Aviv Stock Exchange. To learn more about D-PHARM call Golan Bitton at 972 8 938 5100 or check out http://www.dpharm.com.

D Pharm LTD Alerts

D Pharm LTD is not yet fully synchronised with the market data
D Pharm LTD generates negative expected return over the last 30 days
The company reported revenue of 723K. Net Loss for the year was (814K) with profit before overhead, payroll, taxes, and interest of 723K.
D-PHARM has accumulated about 314K in cash with (313K) of positive cash flow from operations. This results in cash-per-share (CPS) ratio of 0.05.

Market Capitalization

The company currently falls under 'Micro-Cap' category with current market capitalization of 26.75M.


The company has Profit Margin (PM) of (112.59) % which may suggest that it does not properly executes on its current pricing strategies or is unable to control all of the operational costs. This is way below average. Similarly, it shows Operating Margin (OM) of (100.69) % which suggests for every $100 dollars of sales it generated a net operating loss of -1.01.

Management Efficiency

D Pharm LTD has return on total asset (ROA) of (42.09) % which means that it has lost $42.09 on every $100 spent on asset. This is way below average. Similarly, it shows return on equity (ROE) of (400.0) % meaning that it generated substantial loss on money invested by shareholders.

D Pharm Technical and Predictive Indicators

Did you try this?

Run ETF Directory Now


ETF Directory

Find actively-traded Exchange Traded Funds (ETF) from around the world
All  Next Launch ETF Directory

Also Currentnly Active

Purchased few shares of
a day ago
Traded for 1231.54
Purchased few shares of
a day ago
Traded for 183.55
Purchased a lot of shares of
a day ago
Traded for 154.59
Additionally see Investing Opportunities. Please also try Pair Correlation module to compare performance and examine historical correlation between any two equity instruments.
Search macroaxis.com